Gartner Names goBalto, Inc. A 2015 "Cool Vendor In Life Sciences"
Vendors selected for the “Cool Vendor” report are innovative,
impactful and intriguing
SAN FRANCISCO, June 11, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that the company has been included in the Cool Vendors in Life Sciences, 2015 report, published by Gartner, Inc.
Gartner’s Cool Vendor research “is designed to highlight interesting, new and innovative vendors, products and services.”
“We consider goBalto’s inclusion in the Cool Vendor report by Gartner confirmation of our mission to be the world’s leading cloud-based study startup platform,” said Sujay Jadhav, goBalto’s CEO. “Industry leaders in clinical trials continue to show strong adoption of our flagship product, goBalto Activate. Our solution is now being used in hundreds of studies in multiple countries at over 16,000 sites – enabling medicines to get to those in need faster.” According to Jadhav, “The life sciences industry has recognized study startup as one of the worst performing areas in clinical trials.”
Early adopters are leading this disruptive change. “Activate has helped us reduce startup time by 10 weeks. It helps get patients access to the studies faster and helps us manage our business better and build better teams,” said Ryan Conley, Project Manager US Oncology, Novartis.
Gartner also stated, “Many organizations struggle to control costs and resources associated with ramping up clinical trials. It is generally a manually intensive and highly inefficient process. The multistep process of collecting, reviewing and approving regulatory documentation is cumbersome, resulting in millions of dollars of waste per client, and can lead to delays in findings and ultimately, approvals.”
“Startup is expensive, and if you can do it in a reproducible and quicker manner that gives you a competitive edge,” said VP and Global Functional Head, Study Start Up, top 5 CRO. “It also gives our sponsors confidence that when we say we can deliver something in a given time frame that they know it’s going to happen, and they can plan all their downstream activities accordingly.”
About goBalto
goBalto develops next-generation solutions that simplify how clinical trials are started in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Activate, is a purpose-built software-as-a-service clinical research platform. It enables clinical trial sponsors and research organizations to track milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way. Founded in 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.
Help employers find you! Check out all the jobs and post your resume.
SAN FRANCISCO, June 11, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that the company has been included in the Cool Vendors in Life Sciences, 2015 report, published by Gartner, Inc.
Gartner’s Cool Vendor research “is designed to highlight interesting, new and innovative vendors, products and services.”
“We consider goBalto’s inclusion in the Cool Vendor report by Gartner confirmation of our mission to be the world’s leading cloud-based study startup platform,” said Sujay Jadhav, goBalto’s CEO. “Industry leaders in clinical trials continue to show strong adoption of our flagship product, goBalto Activate. Our solution is now being used in hundreds of studies in multiple countries at over 16,000 sites – enabling medicines to get to those in need faster.” According to Jadhav, “The life sciences industry has recognized study startup as one of the worst performing areas in clinical trials.”
Early adopters are leading this disruptive change. “Activate has helped us reduce startup time by 10 weeks. It helps get patients access to the studies faster and helps us manage our business better and build better teams,” said Ryan Conley, Project Manager US Oncology, Novartis.
Gartner also stated, “Many organizations struggle to control costs and resources associated with ramping up clinical trials. It is generally a manually intensive and highly inefficient process. The multistep process of collecting, reviewing and approving regulatory documentation is cumbersome, resulting in millions of dollars of waste per client, and can lead to delays in findings and ultimately, approvals.”
“Startup is expensive, and if you can do it in a reproducible and quicker manner that gives you a competitive edge,” said VP and Global Functional Head, Study Start Up, top 5 CRO. “It also gives our sponsors confidence that when we say we can deliver something in a given time frame that they know it’s going to happen, and they can plan all their downstream activities accordingly.”
About goBalto
goBalto develops next-generation solutions that simplify how clinical trials are started in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Activate, is a purpose-built software-as-a-service clinical research platform. It enables clinical trial sponsors and research organizations to track milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way. Founded in 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.
Help employers find you! Check out all the jobs and post your resume.